{"disease":{"id":"standard-of-care","name":"standard of care"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT07183527","title":"Hybrid Type I Effectiveness-implementation Cluster Randomized Controlled Trial of CARES","phase":"NA","overall_status":"RECRUITING","enrollment_count":1750,"lead_sponsor_name":"University of Pittsburgh","has_results":false},{"nct_id":"NCT06379828","title":"Self-assessment Tool for Implementing the ESCNH","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":100,"lead_sponsor_name":"Global Foundation for the Care of Newborn Infants","has_results":false},{"nct_id":"NCT02003690","title":"Dialectical Behavior Therapy (DBT) for Adolescents With Bipolar Disorder","phase":"NA","overall_status":"COMPLETED","enrollment_count":100,"lead_sponsor_name":"University of Pittsburgh","has_results":false},{"nct_id":"NCT06102200","title":"An Integrated Intervention Involving Recovery Coaching and Cognitive Behavioral Therapy for Opioid Use Disorder","phase":"NA","overall_status":"COMPLETED","enrollment_count":92,"lead_sponsor_name":"Prisma Health-Upstate","has_results":false},{"nct_id":"NCT06315465","title":"Efficacy of MAD as add-on Therapy in Comparison With Standard of Care in Children With ASD","phase":"PHASE2, PHASE3","overall_status":"UNKNOWN","enrollment_count":80,"lead_sponsor_name":"All India Institute of Medical Sciences","has_results":false},{"nct_id":"NCT04364009","title":"Anakinra for COVID-19 Respiratory Symptoms","phase":"PHASE3","overall_status":"TERMINATED","enrollment_count":71,"lead_sponsor_name":"University Hospital, Tours","has_results":false},{"nct_id":"NCT06436508","title":"The Investigation of the Impact of Early Mobilization on the Outcome in Patients With Aneurysmal Subarachnoid Hemorrhage.","phase":"NA","overall_status":"RECRUITING","enrollment_count":50,"lead_sponsor_name":"University of Pecs","has_results":false},{"nct_id":"NCT06803810","title":"Peer to Peer (P2P): Mental Health Interventions With Persons With Substance Use Disorders","phase":"NA","overall_status":"COMPLETED","enrollment_count":40,"lead_sponsor_name":"Prisma Health-Upstate","has_results":false},{"nct_id":"NCT04467515","title":"A Study to Evaluate Safety, Tolerability, Dosimetry, and Preliminary Efficacy of the HER2 Directed Radioligand CAM-H2 in Patients With Advanced/Metastatic HER2-Positive Breast, Gastric, and Gastro-Esophageal Junction (GEJ) Cancer","phase":"PHASE1, PHASE2","overall_status":"TERMINATED","enrollment_count":13,"lead_sponsor_name":"Precirix","has_results":true},{"nct_id":"NCT07011550","title":"Phase 2, Single-arm Trial of BMS-986340 in Association With Nivolumab, Trifluridine/Tipiracil and Bevacizumab for Patients Refractory to Standard of Care Treatment and With Microsatellite-stable Colorectal Cancer","phase":"PHASE2","overall_status":"SUSPENDED","enrollment_count":7,"lead_sponsor_name":"M.D. Anderson Cancer Center","has_results":false}],"total":10},"guidelines":[],"source":"Drug Landscape verified database"}